Descriptor English: | Oxyphenbutazone | ||||||
Descriptor Spanish: |
Oxifenilbutazona
| ||||||
Descriptor Portuguese: | Oxifenilbutazona | ||||||
Descriptor French: | Oxyphenbutazone | ||||||
Entry term(s): |
Diflamil Hydroxyphenylbutazone Oxyphenylbutazone Tanderil |
||||||
Tree number(s): |
D03.383.129.539.850.777.700 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010113 | ||||||
Scope note: | A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27) |
||||||
Annotation: | a non-steroidal anti-inflamm agent |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Inflammatory Agents, Non-Steroidal |
||||||
Registry Number: | H806S4B3NS | ||||||
CAS Type 1 Name: | 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl- | ||||||
Public MeSH Note: | 64 |
||||||
History Note: | 64(63) |
||||||
DeCS ID: | 27753 | ||||||
Unique ID: | D010113 | ||||||
NLM Classification: | QV 95 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1964/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Oxyphenbutazone
- Preferred
Diflamil
- Narrower
Tanderil
- Narrower
Concept UI |
M0015686 |
Scope note | A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27) |
Preferred term | Oxyphenbutazone |
Entry term(s) |
Hydroxyphenylbutazone Oxyphenylbutazone |
Concept UI |
M0473943 |
Preferred term | Diflamil |
Concept UI |
M0473942 |
Preferred term | Tanderil |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey